Bausch Lomb Corp Stock Today
| BLCO Stock | USD 15.75 0.26 1.68% |
PerformanceVery Weak
| Odds Of DistressAbove Average
|
Bausch Lomb is selling at 15.75 as of the 20th of March 2025; that is 1.68% increase since the beginning of the trading day. The stock's open price was 15.49. Bausch Lomb has more than 60 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Bausch Lomb Corporation operates as an eye health company worldwide. The company was founded in 1853 and is headquartered in Vaughan, Canada. Bausch Lomb operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. The company has 352.47 M outstanding shares of which 1.86 M shares are currently shorted by private and institutional investors with about 2.53 trading days to cover. More on Bausch Lomb Corp
Moving together with Bausch Stock
Moving against Bausch Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bausch Stock Highlights
| CEO Chairman | Brenton JD |
| Business Concentration | Medical Equipment, Medical Instruments & Supplies, Healthcare, NYSE Composite, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) |
Bausch Lomb Corp (BLCO) is traded on New York Stock Exchange in USA. It is located in 520 Applewood Crescent, Vaughan, ON, Canada, L4K 4B4 and employs 13,500 people. Bausch Lomb is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.46 B. Bausch Lomb Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 352.47 M outstanding shares of which 1.86 M shares are currently shorted by private and institutional investors with about 2.53 trading days to cover.
Bausch Lomb Corp currently holds about 437 M in cash with 232 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25.
Check Bausch Lomb Probability Of Bankruptcy
Ownership AllocationBausch Lomb holds a total of 352.47 Million outstanding shares. Bausch Lomb Corp shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.41 percent of Bausch Lomb Corp outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bausch Ownership Details
Bausch Lomb Corp Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bausch Lomb market risk premium is the additional return an investor will receive from holding Bausch Lomb long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.10) | |||
| Treynor Ratio | 55.73 |
Bausch Stock Against Markets
Bausch Lomb Corporate Management
| Frederick Munsch | Controller VP | Profile | |
| Joseph Gordon | Surgical Consumer | Profile | |
| Asli Gevgilili | Executive Officer | Profile | |
| Christina Ackermann | Gen VP | Profile | |
| Dennis Asharin | Ex Officer | Profile | |
| Yehia MD | Executive officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Lomb Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Lomb. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Lomb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bausch Lomb Corp is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Lomb's value that differs from its market value or its book value, called intrinsic value, which is Bausch Lomb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Lomb's market value can be influenced by many factors that don't directly affect Bausch Lomb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Lomb's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Lomb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Lomb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.